The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth
jetcityimage / iStock Editorial via Getty Images Lilly posted 53.9% revenue growth and 480% net income growth driven…
‘Complex and largely uncharted’: the grey area of AI
“My AI scribe stopped working first thing this morning,” says Yunzheng Jiao, principal pharmacist in research and clinical…
AI in the Doctor’s Office: How Standards Can Support Trustworthiness
Credit: M. King/NIST When you go to a medical appointment, does the doctor look at you while you…
Understanding the health issues set to dominate 2026
What are the main challenges in global health this year? We reached out to experts to highlight the…
Kate Middleton makes surprise visit to hospital patients with Prince William | Photos
Published on Jan 09, 2026 08:34 pm IST Kate Middleton and Prince William visited Charing Cross Hospital, in…
Obesity, M&A, Biotech Resurgence: A 2026 Guide to Health Stocks
The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth…
‘Shared decision-making’ for childhood vaccines sounds empowering – but it may mean less access for families already stretched thin
When federal health officials announced on Jan. 5, 2026, that they were taking six out of 17 vaccines…
Read Bill Gates’s 2026 annual letter in full
Microsoft co-founder Bill Gates is a seasoned optimist. Even then, 2025 proved an especially difficult pill to swallow.…
57 Fascinating Medical Cases That Might Leave You Amazed, Curious, And Slightly Nauseous
Weekly The week’s finest content carefully selected to bring you the best articles directly [once per week] Daily…
Hong Kong hospital A&E department visits fall 12% after new fees take effect
Visits to accident and emergency (A&E) departments at Hong Kong’s public hospitals have dropped by nearly 12 per…
2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio
Add some stability to your holdings with these healthcare giants. The technology sector is an excellent place to…
Should Investors Be Concerned About This Pharmaceutical Giant’s Latest Clinical Trial?
Key Points Novo Nordisk has released a pill version of its GLP-1 drug. In 2025, the company announced…